Blog

IBSA: STRATEGIC LICENSING AND CDMO PROJECTS FOR THE PHARMACEUTICAL MARKET

IBSA will once again be back at CphI Worldwide 2022, Frankfurt, 1-3 November, to present its innovative solutions for the pharmaceutical market, developed in cutting-edge R&D centers and realized in state-of-the art technology production sites.

Read the Whole Interview
Related Articles
+
11.10.2022
Interview with Chimica Oggi – Chemistry Today
Andrea Toborelli, Business Development and Licensing Manager at IBSA, was interview by Nutra Horizons. 
+
09.10.2022
THE FDA CERTIFIES THE QUALITY OF IBSA FARMACEUTICI: A GUARANTEE OF VALUE FOR PATIENTS
From research to production, from packaging to logistics, from general to administrative services: IBSA Farmaceutici ensures impeccable quality standards in every area of ​​its operations, all guaranteed by control procedures and certifications obtained from the competent Authorities.
+
09.09.2022
IBSA, the 3 generations of hyaluronic acid for infiltrative therapy
IBSA is one of the world leaders in the production of hyaluronic acid by biofermentation.
We’re looking for partners and international distributors for our products.
GET IN TOUCH WITH US
logo-footer

Headquarter

 

Via del Piano, 29
CH 6915
Pambio-Noranco, Lugano
Tel. +41 58 360 10 00

 

 

 

Follow us